EE200200712A - Puriinderivaadid - Google Patents

Puriinderivaadid

Info

Publication number: EE200200712A
Authority: EE; Estonia
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 2000-06-27

Application number

EEP200200712A

Other languages

English (en)

Estonian (et)

Inventor

John Mantell Simon

Marina Monaghan Sandra

Thomas Stephenson Peter

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-27

Filing date

2001-06-14

Publication date

2004-06-15

2001-06-14 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2004-06-15 Publication of EE200200712A publication Critical patent/EE200200712A/xx

Links

229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Neurology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gynecology & Obstetrics (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pregnancy & Childbirth (AREA)

EEP200200712A 2000-06-27 2001-06-14 Puriinderivaadid EE200200712A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0015727.1A GB0015727D0 (en)	2000-06-27	2000-06-27	Purine derivatives
PCT/IB2001/001064 WO2002000676A1 (en)	2000-06-27	2001-06-14	Purine derivatives

Publications (1)

Publication Number	Publication Date
EE200200712A true EE200200712A (et)	2004-06-15

Family

ID=9894500

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200712A EE200200712A (et)	2000-06-27	2001-06-14	Puriinderivaadid

Country Status (42)

Country	Link
EP (1)	EP1296996B1 (xx)
JP (1)	JP2004501929A (xx)
KR (1)	KR20030036248A (xx)
CN (1)	CN1432020A (xx)
AP (1)	AP1372A (xx)
AR (1)	AR028759A1 (xx)
AT (1)	ATE267836T1 (xx)
AU (1)	AU2001264164A1 (xx)
BG (1)	BG107171A (xx)
BR (1)	BR0111912A (xx)
CA (1)	CA2412564C (xx)
CZ (1)	CZ20023992A3 (xx)
DE (1)	DE60103537T2 (xx)
DK (1)	DK1296996T3 (xx)
DO (1)	DOP2001000195A (xx)
EA (1)	EA200201291A1 (xx)
EC (1)	ECSP024396A (xx)
EE (1)	EE200200712A (xx)
ES (1)	ES2220775T3 (xx)
GB (1)	GB0015727D0 (xx)
GT (1)	GT200100119A (xx)
HR (1)	HRP20020995A2 (xx)
HU (1)	HUP0301389A3 (xx)
IL (1)	IL152529A0 (xx)
IS (1)	IS6580A (xx)
MA (1)	MA26918A1 (xx)
MX (1)	MXPA03000078A (xx)
NO (1)	NO20025975D0 (xx)
NZ (1)	NZ521867A (xx)
OA (1)	OA12294A (xx)
PA (1)	PA8521001A1 (xx)
PE (1)	PE20020213A1 (xx)
PL (1)	PL361384A1 (xx)
PT (1)	PT1296996E (xx)
SI (1)	SI1296996T1 (xx)
SK (1)	SK17332002A3 (xx)
SV (1)	SV2002000507A (xx)
TN (1)	TNSN01096A1 (xx)
TR (1)	TR200401622T4 (xx)
UY (1)	UY26797A1 (xx)
WO (1)	WO2002000676A1 (xx)
ZA (1)	ZA200209557B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE340794T1 (de)	2001-08-14	2006-10-15	Lilly Co Eli	Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
SE0201980D0 (sv) *	2002-06-24	2002-06-24	Astrazeneca Ab	Novel compounds
AU2003275257A1 (en)	2002-09-26	2004-04-19	Bristol-Myers Squibb Company	N-substituted heterocyclic amines as modulators of chemokine receptor activity
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
AR049384A1 (es)	2004-05-24	2006-07-26	Glaxo Group Ltd	Derivados de purina
CA2581132A1 (en) *	2004-09-20	2006-03-30	Inotek Pharmaceuticals Corporation	Purine 5'-carboxamide derivatives and their use as adenosine receptor agonists
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
PT2532679T (pt)	2005-10-21	2017-07-18	Novartis Ag	Anticorpos humanos contra il13 e utilizações terapêuticas
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
BRPI0710573A2 (pt) *	2006-04-21	2012-02-28	Novartis Ag	compostos orgánicos, usos e processos para a preparação dos referidos compostos, bem como composição farmacêutica compreendendo os mesmos
US7589076B2 (en) *	2006-05-18	2009-09-15	Pgx Health, Llc	Substituted aryl piperidinylalkynyladenosines as A2AR agonists
CA2664378A1 (en)	2006-09-29	2008-04-03	Novartis Ag	Pyrazolopyrimidines as pi3k lipid kinase inhibitors
BRPI0718266A2 (pt)	2006-10-30	2014-01-07	Novartis Ag	Compostos heterocíclicos como agentes anti-inflamatórios.
US7897737B2 (en)	2006-12-05	2011-03-01	Lasergen, Inc.	3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
EP2231642B1 (en)	2008-01-11	2013-10-23	Novartis AG	Pyrimidines as kinase inhibitors
CN102264917B (zh)	2008-06-11	2015-06-10	激光基因公司	核苷酸和核苷以及将其用于dna测序的方法
WO2010088335A1 (en)	2009-01-29	2010-08-05	Novartis Ag	Substituted benzimidazoles for the treatment of astrocytomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
AU2010283806A1 (en)	2009-08-12	2012-03-01	Novartis Ag	Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
BR112012003709B1 (pt)	2009-08-17	2021-05-18	Intellikine Llc	compostos heterocíclicos e usos dos mesmos
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
WO2012107500A1 (en)	2011-02-10	2012-08-16	Novartis Ag	[1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
CA2828219A1 (en)	2011-02-25	2012-08-30	Irm Llc	Pyrazolo [1,5-a] pyridines as trk inhibitors
UY34329A (es)	2011-09-15	2013-04-30	Novartis Ag	Compuestos de triazolopiridina
CN104363914A (zh)	2011-11-23	2015-02-18	因特利凯有限责任公司	使用mTOR抑制剂的增强的治疗方案
CN110507654A (zh)	2012-04-03	2019-11-29	诺华有限公司	有酪氨酸激酶抑制剂的组合产品和其应用
WO2014151147A1 (en)	2013-03-15	2014-09-25	Intellikine, Llc	Combination of kinase inhibitors and uses thereof
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
CA2954862A1 (en)	2014-07-31	2016-02-04	Novartis Ag	Combination therapy
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8276187A (en) *	1986-10-31	1988-05-25	Warner-Lambert Company	Selected n6-substituted adenosines having selective a2 binding activity
IL107101A0 (en) *	1992-09-30	1993-12-28	Merrell Dow Pharma	2-substituted adenosines with a-2 receptor affinity
GB9723590D0 (en) *	1997-11-08	1998-01-07	Glaxo Group Ltd	Chemical compounds
JP2002500188A (ja) *	1998-01-08	2002-01-08	ザ・ユニバーシティ・オブ・バージニア・パテント・ファウンデーション	Ａ２ａアデノシンレセプター作動因子
BR9914526A (pt) *	1998-10-16	2001-07-03	Pfizer	Derivados de adenina
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB9924361D0 (en) *	1999-10-14	1999-12-15	Pfizer Ltd	Purine derivatives
GB9924363D0 (en) *	1999-10-14	1999-12-15	Pfizer Central Res	Purine derivatives

2000
- 2000-06-27 GB GBGB0015727.1A patent/GB0015727D0/en not_active Ceased
2001
- 2001-06-14 DE DE60103537T patent/DE60103537T2/de not_active Expired - Fee Related
- 2001-06-14 BR BR0111912-5A patent/BR0111912A/pt not_active IP Right Cessation
- 2001-06-14 OA OA1200200387A patent/OA12294A/en unknown
- 2001-06-14 WO PCT/IB2001/001064 patent/WO2002000676A1/en not_active Application Discontinuation
- 2001-06-14 SK SK1733-2002A patent/SK17332002A3/sk unknown
- 2001-06-14 NZ NZ521867A patent/NZ521867A/en unknown
- 2001-06-14 TR TR2004/01622T patent/TR200401622T4/xx unknown
- 2001-06-14 EP EP01938490A patent/EP1296996B1/en not_active Expired - Lifetime
- 2001-06-14 PL PL36138401A patent/PL361384A1/xx not_active Application Discontinuation
- 2001-06-14 HU HU0301389A patent/HUP0301389A3/hu unknown
- 2001-06-14 MX MXPA03000078A patent/MXPA03000078A/es active IP Right Grant
- 2001-06-14 AT AT01938490T patent/ATE267836T1/de not_active IP Right Cessation
- 2001-06-14 KR KR1020027017723A patent/KR20030036248A/ko not_active Application Discontinuation
- 2001-06-14 PT PT01938490T patent/PT1296996E/pt unknown
- 2001-06-14 CN CN01810621A patent/CN1432020A/zh active Pending
- 2001-06-14 SI SI200130136T patent/SI1296996T1/xx unknown
- 2001-06-14 JP JP2002505798A patent/JP2004501929A/ja active Pending
- 2001-06-14 CA CA002412564A patent/CA2412564C/en not_active Expired - Fee Related
- 2001-06-14 CZ CZ20023992A patent/CZ20023992A3/cs unknown
- 2001-06-14 EE EEP200200712A patent/EE200200712A/xx unknown
- 2001-06-14 DK DK01938490T patent/DK1296996T3/da active
- 2001-06-14 IL IL15252901A patent/IL152529A0/xx unknown
- 2001-06-14 EA EA200201291A patent/EA200201291A1/ru unknown
- 2001-06-14 AU AU2001264164A patent/AU2001264164A1/en not_active Abandoned
- 2001-06-14 ES ES01938490T patent/ES2220775T3/es not_active Expired - Lifetime
- 2001-06-21 GT GT200100119A patent/GT200100119A/es unknown
- 2001-06-21 AP APAP/P/2001/002193A patent/AP1372A/en active
- 2001-06-22 DO DO2001000195A patent/DOP2001000195A/es unknown
- 2001-06-25 PA PA20018521001A patent/PA8521001A1/es unknown
- 2001-06-25 PE PE2001000615A patent/PE20020213A1/es not_active Application Discontinuation
- 2001-06-26 UY UY26797A patent/UY26797A1/es not_active Application Discontinuation
- 2001-06-26 TN TNTNSN01096A patent/TNSN01096A1/fr unknown
- 2001-06-26 SV SV2001000507A patent/SV2002000507A/es not_active Application Discontinuation
- 2001-06-26 AR ARP010103038A patent/AR028759A1/es unknown
2002
- 2002-10-07 BG BG107171A patent/BG107171A/xx unknown
- 2002-10-10 IS IS6580A patent/IS6580A/is unknown
- 2002-11-25 ZA ZA200209557A patent/ZA200209557B/en unknown
- 2002-12-12 NO NO20025975A patent/NO20025975D0/no not_active Application Discontinuation
- 2002-12-12 HR HR20020995A patent/HRP20020995A2/hr not_active Application Discontinuation
- 2002-12-19 EC EC2002004396A patent/ECSP024396A/es unknown
- 2002-12-20 MA MA26970A patent/MA26918A1/fr unknown

Also Published As

Publication number	Publication date
PE20020213A1 (es)	2002-03-19
AP1372A (en)	2005-02-21
NO20025975L (no)	2002-12-12
TR200401622T4 (tr)	2004-08-23
HUP0301389A2 (hu)	2003-08-28
SI1296996T1 (en)	2004-10-31
DOP2001000195A (es)	2002-05-15
EA200201291A1 (ru)	2003-04-24
TNSN01096A1 (fr)	2005-11-10
DK1296996T3 (da)	2004-08-16
CZ20023992A3 (cs)	2003-12-17
AU2001264164A1 (en)	2002-01-08
JP2004501929A (ja)	2004-01-22
BR0111912A (pt)	2003-05-13
PT1296996E (pt)	2004-08-31
PL361384A1 (en)	2004-10-04
GT200100119A (es)	2002-01-31
WO2002000676A1 (en)	2002-01-03
HUP0301389A3 (en)	2005-02-28
IS6580A (is)	2002-10-10
EP1296996B1 (en)	2004-05-26
SV2002000507A (es)	2002-07-03
AR028759A1 (es)	2003-05-21
ECSP024396A (es)	2003-02-06
IL152529A0 (en)	2003-05-29
NO20025975D0 (no)	2002-12-12
BG107171A (en)	2003-07-31
MA26918A1 (fr)	2004-12-20
NZ521867A (en)	2004-04-30
ES2220775T3 (es)	2004-12-16
GB0015727D0 (en)	2000-08-16
ATE267836T1 (de)	2004-06-15
PA8521001A1 (es)	2002-04-25
HRP20020995A2 (en)	2005-02-28
DE60103537T2 (de)	2005-07-07
UY26797A1 (es)	2002-01-31
SK17332002A3 (sk)	2004-03-02
ZA200209557B (en)	2003-12-02
KR20030036248A (ko)	2003-05-09
OA12294A (en)	2003-11-14
CA2412564C (en)	2007-10-02
EP1296996A1 (en)	2003-04-02
MXPA03000078A (es)	2003-08-19
CN1432020A (zh)	2003-07-23
DE60103537D1 (de)	2004-07-01
CA2412564A1 (en)	2002-01-03

Publication	Publication Date	Title
ATE325807T1 (de)	2006-06-15	Purinderivate
DE60103537D1 (de)	2004-07-01	Purinderivate
ATE431356T1 (de)	2009-05-15	2-aminocarbonyl-9h-purinderivative
DE60116260D1 (de)	2006-02-02	Antivirale azaindolderivate
DE60026861D1 (de)	2006-05-11	Purin-derivate
DK1220863T3 (da)	2003-08-11	Purinderivater
EE200100681A (et)	2003-04-15	Puriinderivaadid
DE60130463D1 (de)	2007-10-25	Pyrimidin-derivate
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
AR028282A1 (es)	2003-04-30	Derivados de aminofenil pirimidona
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
ATE280752T1 (de)	2004-11-15	Aminomethyl-phenyl-cyclohexanonderivate
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater